The mouse as a model for neuropsychiatric drug development
- 1 September 2018
- journal article
- editorial
- Published by Elsevier in Current Biology
- Vol. 28 (17) , R909-R914
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01AG056259, R01NS086890, DP1DA041722, RF1AG057409)
This publication has 20 references indexed in Scilit:
- Animal versus human oral drug bioavailability: Do they correlate?European Journal of Pharmaceutical Sciences, 2014
- Cortical Evolution: Judge the Brain by Its CoverNeuron, 2013
- Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substratesNeuroscience & Biobehavioral Reviews, 2012
- How were new medicines discovered?Nature Reviews Drug Discovery, 2011
- Animal models of neuropsychiatric disordersNature Neuroscience, 2010
- Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathwaysProceedings of the National Academy of Sciences, 2010
- Can Animal Models of Disease Reliably Inform Human Studies?PLOS Medicine, 2010
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal ModelsNeuropsychopharmacology, 2008
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002